Top compounds associated with response to ELL2


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 2e-07
mRNA barasertib CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA FK866 CTRPv2 pan-cancer AAC -0.19 5e-07
mRNA PIK-93 GDSC1000 pan-cancer AAC -0.15 1e-06
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.15 1e-06
mRNA clofarabine CTRPv2 pan-cancer AAC -0.14 2e-06
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 3e-06
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA decitabine CTRPv2 pan-cancer AAC -0.13 4e-06
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.16 4e-06
Download CSV